ATH 0.00% 0.4¢ alterity therapeutics limited

Finally Moving North, page-4

  1. 2,818 Posts.
    lightbulb Created with Sketch. 987
    I am waiting not only for something about the open study. In some meetings, blood results (neurofilament light, alpha-synuclein) can be reported earlier than the iron in the brain.

    PBT2 news
    - Masters's license in AD, progression?
    - Dr Neville's news on antibiotic resistance, 3 years have passed, and she will have results about her otitis project planned to last 3 years

    ATH434
    - more primate study results, a scientific meeting??? Alpha-synuclein info was still missing, for some reason.
    - New grant application to M Fox Foundation or new promised grant for PD phase 2 study
    - Finkelstein et al: an abstract about ATH434 and eye changes (PD, retina degeneration in general, diabetic retina etc.)
    - preclinical report about traumatic brain injury

    Other news about the patented molecules

    Rumors about big pharma deal, preliminary discussions.

    else ???




 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.4¢
Change
0.000(0.00%)
Mkt cap ! $18.62M
Open High Low Value Volume
0.3¢ 0.4¢ 0.3¢ $2.017K 651.8K

Buyers (Bids)

No. Vol. Price($)
45 55401134 0.3¢
 

Sellers (Offers)

Price($) Vol. No.
0.4¢ 128936244 21
View Market Depth
Last trade - 15.24pm 04/09/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.